Integra Lifesciences Holdings Stock Performance
| IART Stock | USD 24.24 0.66 2.80% |
On a scale of 0 to 100, Integra LifeSciences holds a performance score of 6. The company retains a Market Volatility (i.e., Beta) of 1.06, which attests to a somewhat significant risk relative to the market. Integra LifeSciences returns are very sensitive to returns on the market. As the market goes up or down, Integra LifeSciences is expected to follow. Please check Integra LifeSciences' potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether Integra LifeSciences' current trending patterns will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Integra LifeSciences Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Integra LifeSciences unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.53 | Five Day Return 5.28 | Year To Date Return (44.65) | Ten Year Return (1.78) | All Time Return 417.64 |
Last Split Factor 2:1 | Last Split Date 2017-01-04 |
1 | Disposition of 1412 shares by Veillon-berteloot Chantal of Integra LifeSciences at 20.34 subject to Rule 16b-3 | 08/30/2024 |
2 | You Can Buy a 300-HP BMW That Looks Like A Civic For The Price Of A Civic | 10/18/2024 |
3 | Acquisition by Graves Jeffrey A of 8696 shares of Integra LifeSciences subject to Rule 16b-3 | 10/29/2024 |
4 | Why Is Integra LifeSciences Stock Soaring On Monday | 11/04/2024 |
5 | Theres No Escaping Integra LifeSciences Holdings Corporations Muted Revenues Despite A 42 percent Share Price Rise | 11/05/2024 |
6 | Integra LifeSciences Shares Gap Up After Better-Than-Expected Earnings | 11/06/2024 |
7 | INTEGRA RESOURCES COMPLETES TRANSACTION WITH FLORIDA CANYON GOLD, CREATING A NEW GREAT BASIN PRECIOUS METALS PRODUCER | 11/08/2024 |
8 | Capital Research Global Investors Reduces Stake in Integra Lifesciences Holdings Corp | 11/13/2024 |
9 | IART Stock to Gain From New Study Findings on DuraSeal Dural Sealant | 11/14/2024 |
10 | 8 Luxury Cars With the Best Gas Mileage in 2025 | 11/19/2024 |
| Begin Period Cash Flow | 456.7 M |
Integra |
Integra LifeSciences Relative Risk vs. Return Landscape
If you would invest 2,052 in Integra LifeSciences Holdings on August 27, 2024 and sell it today you would earn a total of 372.00 from holding Integra LifeSciences Holdings or generate 18.13% return on investment over 90 days. Integra LifeSciences Holdings is currently generating 0.3337% in daily expected returns and assumes 4.0253% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than Integra, and 94% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Integra LifeSciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Integra LifeSciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Integra LifeSciences Holdings, and traders can use it to determine the average amount a Integra LifeSciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0829
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IART | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.03 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.33 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Integra LifeSciences is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Integra LifeSciences by adding it to a well-diversified portfolio.
Integra LifeSciences Fundamentals Growth
Integra Stock prices reflect investors' perceptions of the future prospects and financial health of Integra LifeSciences, and Integra LifeSciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Integra Stock performance.
| Return On Equity | -0.0042 | ||||
| Return On Asset | 0.0302 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 3.53 B | ||||
| Shares Outstanding | 77.16 M | ||||
| Price To Earning | 26.94 X | ||||
| Price To Book | 1.20 X | ||||
| Price To Sales | 1.16 X | ||||
| Revenue | 1.54 B | ||||
| Gross Profit | 982.03 M | ||||
| EBITDA | 383.57 M | ||||
| Net Income | 67.74 M | ||||
| Cash And Equivalents | 451.52 M | ||||
| Cash Per Share | 5.41 X | ||||
| Total Debt | 1.68 B | ||||
| Debt To Equity | 1.03 % | ||||
| Current Ratio | 3.85 X | ||||
| Book Value Per Share | 19.73 X | ||||
| Cash Flow From Operations | 139.96 M | ||||
| Earnings Per Share | (0.09) X | ||||
| Market Capitalization | 1.82 B | ||||
| Total Asset | 3.78 B | ||||
| Retained Earnings | 946.86 M | ||||
| Working Capital | 751.06 M | ||||
| Current Asset | 438.5 M | ||||
| Current Liabilities | 139.13 M | ||||
About Integra LifeSciences Performance
Assessing Integra LifeSciences' fundamental ratios provides investors with valuable insights into Integra LifeSciences' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Integra LifeSciences is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 217.71 | 170.42 | |
| Return On Tangible Assets | 0.04 | 0.04 | |
| Return On Capital Employed | 0.03 | 0.03 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.04 | 0.04 |
Things to note about Integra LifeSciences performance evaluation
Checking the ongoing alerts about Integra LifeSciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Integra LifeSciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Integra LifeSciences had very high historical volatility over the last 90 days | |
| Integra LifeSciences has a strong financial position based on the latest SEC filings | |
| Over 93.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: 8 Luxury Cars With the Best Gas Mileage in 2025 |
- Analyzing Integra LifeSciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Integra LifeSciences' stock is overvalued or undervalued compared to its peers.
- Examining Integra LifeSciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Integra LifeSciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Integra LifeSciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Integra LifeSciences' stock. These opinions can provide insight into Integra LifeSciences' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.